Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
Sixty-years of community-science data suggest earlier fall migration and short-stopping of several species of waterfowl in North America
<p>Worldwide, migratory phenology and movement of many bird species are shifting in response to anthropogenic climate and habitat changes. However, due to variation among species and a shortage of analyses, changes in waterfowl migration, particularly in the fall, are not well understood. Fall migration phenology and movement patterns dictate waterfowl hunting success and satisfaction, with cascading implications on economies and support for habitat management and securement. Using 60 years of band recovery data for waterfowl banded in the Canadian Prairie Pothole Region (PPR), we evaluated whether fall migration timing and/or distribution changed in Mallard (<em>Anas</em> <em>platyrhynchos</em>), Northern Pintail (<em>A. acuta</em>), and Blue-winged Teal (<em>Spatula</em> <em>discors</em>) between 1960 and 2019. We found that in the Midcontinent Flyways, Mallards and Blue-winged Teal migrated faster in more recent time periods, while Northern Pintail began fall migration earlier. In the Pacific Flyway, Mallards began fall migration earlier. Both Mallards and Northern Pintails showed evidence of short-stopping in the Midcontinent Flyways. Indeed, the Mallard and Northern Pintail distribution of band recovery data shifted 180 km and 226 km north respectively from 1960 to 2019. Conversely, Blue-winged Teal recovery distributions were consistent across years. Mallards and Northern Pintails also exhibited an increased proportion of band recoveries in the Pacific Flyway in recent decades. We provide clear evidence that the timing and routes of fall migration have shifted over the past six decades, but these phenological and spatial shifts differ among species. We suggest that using community-science data collected by hunters themselves to explain one of the group's major concerns (changes in duck abundance at traditional hunting grounds), within the environmental lens of climate change, may help lead to further engagement and two-way dialogue to support effective waterfowl management for these culturally and ecologically important species. </p>
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
ClinicalTrials.gov study NCT03345836. IPD Sharing: YES. Countries: 48. Publications: 7.
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
ClinicalTrials.gov study NCT03627091. IPD Sharing: YES. Countries: 34. Publications: 1.
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03020199. IPD Sharing: YES. Countries: 13. Publications: 0.
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov study NCT03926169. IPD Sharing: YES. Countries: 8. Publications: 1.
Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control
ClinicalTrials.gov study NCT02483572. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
ClinicalTrials.gov study NCT03417102. IPD Sharing: YES. Countries: 17. Publications: 3.
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
ClinicalTrials.gov study NCT02563067. IPD Sharing: UNDECIDED. Countries: 19. Publications: 1.
Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B
ClinicalTrials.gov study NCT02234310. IPD Sharing: YES. Countries: 11. Publications: 2.
A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03706040. IPD Sharing: YES. Countries: 5. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
ClinicalTrials.gov study NCT03930732. IPD Sharing: YES. Countries: 24. Publications: 5.
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs
ClinicalTrials.gov study NCT01857583. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
ClinicalTrials.gov study NCT03549871. IPD Sharing: YES. Countries: 15. Publications: 1.
A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)
ClinicalTrials.gov study NCT03093480. IPD Sharing: YES. Countries: 10. Publications: 1.
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
ClinicalTrials.gov study NCT02615691. IPD Sharing: YES. Countries: 23. Publications: 1.
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT02353871. IPD Sharing: YES. Countries: 2. Publications: 1.
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
ClinicalTrials.gov study NCT04035668. IPD Sharing: YES. Countries: 12. Publications: 1.
Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.
ClinicalTrials.gov study NCT03988608. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload
ClinicalTrials.gov study NCT01254227. IPD Sharing: YES. Countries: 8. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.